In our study, we observed that intervention with solanine affected the EGFR-mediated PI3K/Akt/NF-κB signaling pathway, effectively reducing inflammation, cell proliferation, and angiogenesis in aggressive drug-resistant oral carcinoma cells. The gene discussed is NFKB1; the disease is lip and oral cavity carcinoma.